Radiopharm Theranostics Limited (RADX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Radiopharm Theranostics L...

    NASDAQ: RADX · Real-Time Price · USD
    6.75
    0.55 (8.87%)
    At close: Oct 06, 2025, 12:56 PM

    Radiopharm Theranostics Ratios and Metrics

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
    PE Ratio
    		 -1.28 -0.71 -0.78 -0.86
    PEG Ratio
    		 0.01 -0.08 -0.07 n/a
    PS Ratio
    		 13.46 114.19 92.46 2.95K
    PB Ratio
    		 1.09 1.22 0.61 0.41
    P/FCF Ratio
    		 -1.33 -1.49 -1.09 -0.68
    P/OCF Ratio
    		 -1.33 -1.49 -1.17 -2.63
    OCF/S Ratio
    		 -10.09 -76.78 -79.36 -1.12K
    Debt / Equity Ratio
    		 n/a n/a n/a n/a
    Quick Ratio
    		 2.67 1.30 1.23 3.46
    Current Ratio
    		 2.67 1.30 1.23 3.46
    Asset Turnover
    		 0.04 0.00 0.00 0.00
    Interest Coverage
    		 -584.59 -56.96 -400.83 -2.13
    Return on Equity
    		 -0.86 -1.71 -0.78 -0.48
    Return on Assets
    		 -0.44 -0.67 -0.46 -0.36
    Return on Invested Capital
    		 -0.53 -0.67 -0.56 -0.26
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.01 1.00 1.00 1.00
    Net Profit Margin
    		 -10.55 -160.24 -118.39 -3.44K
    Pretax Profit Margin
    		 -10.52 -159.92 -118.26 -3.43K
    Operating Profit Margin
    		 -10.51 -122.38 -118.03 -2.26K
    FCF Margin
    		 -10.09 -76.78 -84.6 -4.33K
    EBITDA Margin
    		 -10.5 -147.32 -106.69 -2.03K

    Add to Watchlist